Enfusion To Present at Upcoming Investor Events
Enfusion (NYSE: ENFN), a leading SaaS solutions provider for investment managers, has announced its executive participation in two upcoming investor events. Chief Financial Officer Brad Herring and Chief Operating Officer Neal Pawar will attend the Wells Fargo 8th Annual TMT Summit on December 3, 2024, and the UBS Global Technology and AI Conference on December 4, 2024. Live audio webcasts and archived replays will be accessible through Enfusion's Investor Relations website.
Enfusion (NYSE: ENFN), un fornitore leader di soluzioni SaaS per gestori di investimenti, ha annunciato la sua partecipazione esecutiva a due prossimi eventi per investitori. Il Direttore Finanziario Brad Herring e Il Direttore Operativo Neal Pawar parteciperanno al Wells Fargo 8° Summit TMT Annuale il 3 dicembre 2024, e alla Conferenza Globale sulla Tecnologia e AI di UBS il 4 dicembre 2024. Le trasmissioni audio in diretta e le registrazioni archiviate saranno accessibili attraverso il sito web delle Relazioni con gli Investitori di Enfusion.
Enfusion (NYSE: ENFN), un proveedor líder de soluciones SaaS para gestores de inversiones, ha anunciado su participación ejecutiva en dos próximos eventos para inversores. El Director Financiero Brad Herring y El Director de Operaciones Neal Pawar asistirán al 8° Summit TMT Anual de Wells Fargo el 3 de diciembre de 2024, y a la Conferencia Global de Tecnología y AI de UBS el 4 de diciembre de 2024. Las transmisiones de audio en vivo y las repeticiones archivadas estarán disponibles a través del sitio web de Relaciones con Inversores de Enfusion.
Enfusion (NYSE: ENFN), 투자 관리자를 위한 선도적인 SaaS 솔루션 제공업체가 두 가지 예정된 투자자 행사에 임원급 참여를 발표했습니다. 재무 담당 최고 책임자 브래드 헤링과 운영 담당 최고 책임자 닐 파와르는 2024년 12월 3일 웰스파고 제8회 연례 TMT 서밋과 2024년 12월 4일 UBS 글로벌 기술 및 AI 컨퍼런스에 참석할 예정입니다. 실시간 오디오 웹캐스트와 아카이브된 재생은 Enfusion의 투자자 관계 웹사이트를 통해 접속할 수 있습니다.
Enfusion (NYSE: ENFN), un fournisseur leader de solutions SaaS pour les gestionnaires d'investissement, a annoncé sa participation executive à deux événements pour investisseurs à venir. Le Directeur Financier Brad Herring et Le Directeur des Opérations Neal Pawar assisteront au 8ème Sommet TMT Annuel de Wells Fargo le 3 décembre 2024, et à la Conférence Mondiale sur la Technologie et l'IA de UBS le 4 décembre 2024. Les webcasts audio en direct et les rediffusions archivées seront accessibles via le site Web des Relations Investisseurs d'Enfusion.
Enfusion (NYSE: ENFN), ein führender Anbieter von SaaS-Lösungen für Investmentmanager, hat seine Teilnahme an zwei bevorstehenden Investorenevents bekannt gegeben. Finanzvorstand Brad Herring und Betriebsleiter Neal Pawar werden am 8. jährlichen TMT-Gipfel von Wells Fargo am 3. Dezember 2024 sowie an der UBS Global Technology and AI Conference am 4. Dezember 2024 teilnehmen. Live-Audio-Webcasts und archivierte Wiederholungen sind über Enfusions Investor Relations-Website zugänglich.
- None.
- None.
- Wells Fargo 8th Annual TMT Summit on Tuesday, December 3, 2024
- UBS Global Technology and AI Conference on Wednesday, December 4, 2024
Live audio webcasts and archived replays of the events will be available in the Events & Presentations section of the Enfusion Investor Relations website at http://ir.enfusion.com.
About Enfusion
Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents.
Source: Enfusion, Inc.
Source Code: ENFN-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20241119246594/en/
Investors
Bill Wright
investors@enfusion.com
Media
media@enfusion.com
Source: Enfusion, Inc.
FAQ
What investor events will Enfusion (ENFN) attend in December 2024?
Which Enfusion (ENFN) executives will present at the 2024 investor conferences?
Where can investors access Enfusion's (ENFN) December 2024 conference presentations?